FASLG and colonic neoplasm: This is the first study where characterised low passage tumorigenic primary human colon cancer cell lines PAP60 and MIH55 have been analysed in vitro (cell culture) and in vivo (SCID mice) for their sensitivity to TRAIL- and FASL-induced apoptosis administered as single agents.